Almirall, from Spain

Listed in:

Business: Chemistry, Pharmaceutical, Healthcare,

Auditor: PWC.

Last Balances States (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Total Assets 1,799.341 1,332.409 35.04
Total Liabilities
892.024
392.491 127.27
Equity
907.317
939.918 -3.47
Working Capital
9.625
54.933 -82.48
March 10, 2016

Basic Stock Information

Last Quote (EUR)
15.270
PER
-78.33
Capitalization (Mns of EUR)
2,640.964
Capitalization/Equity
2.9107
Last month variation (%)
-7.117
Last 3 months variation (%)
-14.978
Last 6 months variation (%)
-8.288
Last 12 months variation (%)
3.666

Last Financial Statement (Mn of EUR)

Date H1-2014 H1-2013 Var (%)
Revenue
403.742
343.768 17.45
EBIT
18.914
6.357 197.53
Net Profit
19.074
17.648 8.08
ROCE (%) 1.299 0.576 125.52
ROE 0.021 0.019 10.53
ROA 0.011 0.013 -15.38
Net Profit over revenue 0.047 0.051 -7.84
EBIT over revenue 0.047 0.018 161.11
EBITDA over revenue 0.152 0.121 25.62
Assets Rotation 0.224 0.258 -13.18
Earning per share (EUR) 0.11029 0.10204 8.09

Stock-Market Evolution

Key Figures (EUR)

Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
H1 403.742 61.220 18.914 9.157 19.074 0.047 0.047 0.021 0.011 9.625 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 692.891 -4.491 -84.352 -89.729 -33.717 -0.049 -0.122 -0.038 -0.019 -63.485 Details
H2 349.123 -45.924 -90.709 -93.971 -51.365 -0.147 -0.260 -0.058 -0.029 -63.485 Details
H1 343.768 41.433 6.357 4.242 17.648 0.051 0.018 0.019 0.013 54.933 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 682.882 123.271 53.450 48.820 76.291 0.112 0.078 0.083 0.056 60.959 Details
H2 308.861 73.164 36.201 33.354 49.200 0.159 0.117 0.053 0.036 60.959 Details
H1 374.021 50.323 17.249 15.466 27.091 0.072 0.046 0.031 0.020 94.799 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 768.418 149.835 77.302 71.972 84.166 0.110 0.101 0.098 0.058 45.094 Details
H2 341.925 37.760 -2.458 -2.572 16.395 0.048 -0.007 0.019 0.011 45.094 Details
H1 426.493 112.075 79.760 74.544 67.771 0.159 0.187 0.081 0.044 102.129 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 882.438 205.618 128.275 119.181 118.604 0.134 0.145 0.145 0.077 166.492 Details
H2 413.397 70.454 24.701 18.558 31.659 0.077 0.060 0.039 0.021 166.492 Details
H1 469.041 135.164 103.574 100.623 86.945 0.185 0.221 0.111 0.060 206.355 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 925.486 237.363 188.635 171.490 151.494 0.164 0.204 0.202 0.102 196.165 Details
H2 436.700 92.252 52.787 44.403 48.140 0.110 0.121 0.064 0.032 196.165 Details
H1 488.786 145.111 135.848 127.087 103.354 0.211 0.278 0.147 0.072 129.933 Details
Period Revenue EBITDA EBIT Earning before taxes Net Profit Net Profit over revenue EBIT over revenue ROE ROA Working Capital
Annual 902.827 230.024 162.446 144.722 136.137 0.151 0.180 0.208 0.097 127.410 Details
H2 434.890 91.900 55.127 46.740 50.613 0.116 0.127 0.078 0.036 127.410 Details
H1 467.937 138.124 107.319 97.982 85.524 0.183 0.229 0.140 0.063 128.097 Details

Additional information

  • Capitalization: Total number of shares x (1 - Treasury shares) x Last Quote = (172951120) x (1 - 0.000 ) x (15.270 EUR) = 2640.964 Mns of EUR
  • PER: Last Quote (15.270 EUR) / Last annual earning per share (-0.19495) = -78.328

News